Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Amphion Innovations reveals new report implying increased valuation for Polarean Imaging

The group develops equipment that enables existing MRI systems to achieve an improved level of imaging
MRI scanner with medic alongside
Pictured is an MRI scanner

Medical and technology investor Amphion Innovations Plc (LON:AMP) has updated on the credentials of its portfolio firm Polarean Imaging Limited, saying the float on AIM is progressing.

Polarean, which is a specialist in MRI technology, is being prepared for an AIM market float this year– after raising US$2mln in pre-IPO financing during 2016.

READ: Amphion Innovations unit DataTern says it is confident its patents are valid after US court setback

The group develops equipment that enables existing MRI systems to achieve an improved level of lung function imaging.

Significantly, it has clear guidance from the US FDA on the start of a pivotal Phase III trial on its flagship drug-device platform.

Amphion said that Northland Capital Partners, acting as Polarean's joint corporate broker, has today published a research report ahead of an investor roadshow.

READ: Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success

The report anticipates a pre-IPO valuation of Polarean of around US$29 mln, compared with the valuation of circa US$22mln(on a post new money basis) implied by the pre-IPO fundraise of US$2 million in May this year.

Amphion has an interest in around 26% of the firm.

View full AMP profile View Profile

Amphion Innovations Plc Timeline

Related Articles

June 14 2018
“[PeopleFluent] brings interesting technologies back to us … particularly in terms of interactive video and social collaboration tools”
Video game media with player
August 21 2018
Analysts at German bank Berenberg have upped their target price for the firm to 2,150p from 2,060p, saying the company's market is expected to "outgrow the video game segment"
ai graphic
August 26 2018
The company helps commercialise innovations developed in universities around the world. The shares are trading at a 40% discount to the value of its current basket of investments

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use